MLNT Data
Melinta Therapeutics Inc. (Nasdaq:MLNT) » Social Data - Financial Data - Research - Charts
SpeculatingStocks › Pulse Portal › MLNT Data
Data Last Updated: More than 3 wks ago
↻ Update MLNT Data to Most Recent
Follow Important Email Alerts on Stocks from SpeculatingStocks.com.
Sign up for Our Email Newsletter.
-
$MLNT | Melinta Therapeutics Inc. Social Data » 1) Follower Data, 2) Sentiment Data, 3) Posts Data | Data Mined from SpeculatingStocks Pulse Social Network
Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.
MLNT Follower Data
Followers: 0
MLNT Sentiment Data
'Buys': 0 | 'Sells': 0
'Buys' Yesterday: 0 | 'Sells' Yesterday: 0
B/S Rating Today: 0 | B/S Rating All-Time: 0
MLNT Posts Data
Avg. Number of Pulses a Day: 1.15 | Total Number of Pulses All-Time: 877
Total Number of Pulses Yesterday: 0
More: $MLNT (Melinta Therapeutics Inc.) Stream, Posts, and Sentiment Page
MLNT Financial Data
-
MLNT | Melinta Therapeutics Inc. Financial Data » 1) Annual Financials, 2) Quarterly Financials, and 3) Key Metrics
Market Cap: $27.614M
MLNT Annual Financials (Most Recent Fiscal Year)
Income Statement:Revenue: $96.43M
Net Income: $(157.19M)
Cash Flow Statement:
Change in Cash / Cash Equiv.: $(46.58M)
Balance Sheet:
Cash / Cash Equiv. + ST Investments: $81.81M
Short Term Debt: None
Long Term Debt: $110.48M
Total Current Assets: $149.48M
Total Current Liabilities: $133.61M
Total Assets: $441.59M
Total Liabilities: $251.53M
Stockholder Equity: $190.06M
Annual MLNT Cash Flow Statement
MLNT Quarterly Financials (Most Recent Q)
Income Statement:
Revenue: $15.96M
Net Income: $(36.18M)
Cash Flow Statement:
Change in Cash / Cash Equiv.: $(26.56M)
Balance Sheet:
Cash / Cash Equiv. + ST Investments: $90.34M
Short Term Debt: $13.79M
Long Term Debt: $157.06M
Total Current Assets: $156.76M
Total Current Liabilities: $132.39M
Total Assets: $440.37M
Total Liabilities: $298.71M
Stockholder Equity: $141.67M
Quarterly MLNT Income Statement
Quarterly MLNT Cash Flow Statement
MLNT Key Metrics
Market Cap: $27.614M
Trailing PE: N/A
Price to Sales (Based on Most Recent Annual Revenue): 0.29
Price to Book (Based on Most Recent Quarter Stockholder Equity): 0.19
Beta: 7.14
More Key MLNT Financial Metrics
Please Give Tips to Others about Insight Gained from MLNT Financials
Share: 1) Share Your Opinion of MLNT, 2) Place a 'Buy' or 'Sell' Sentiment on MLNT
MLNT Research
-
MLNT | Melinta Therapeutics Inc. Research » 1) Share Data, 2) Short Data, 3) Insider Data, and 4) Corporate Data
MLNT Share Data
Outstanding Shares: 11.78M
Shares in Float: 10.37M
MLNT Short Data
Percent of Float Short: 19.93%
Shares Short: 2.07M
MLNT Insider Data
Shares Held by Insiders: N/A
Shares Held by Institutions: N/A
MLNT Corporate Data
CEO: Ms. Jennifer A. Sanfilippo
Employees: 290
Please Give Tips to Others about Insight Gained from MLNT Research
Share: 1) Share Your Opinion of MLNT, 2) Place a 'Buy' or 'Sell' Sentiment on MLNT

MLNT Charts

MLNT Social Data